Regional fertility care provider Fertility Answers was recently chosen to participate in a new national clinical research trial sponsored by Ferring Pharmaceuticals, one of only 22 clinical sites in the United States chosen to participate. Ferring Pharmaceuticals CLARA drug trial will evaluate a new medication delivery system for the pharmaceutical drug MENOPUR used in in vitro fertilization protocols. As part of the national study, Fertility Answers will be recruiting up to 20 patients to undergo in vitro fertilization using the new medication delivery system. Eligible patients will include infertile women between the ages of 18-42, with regular cycles, and a BMI less than 38. Qualified and enrolled patients will receive one IVF cycle with a fresh embryo transfer at no cost.
2 days ago